"targeted therapy" trang 3 - tải miễn phí từ tailieuXANH
How are we evaluating the costeffectiveness of companion biomarkers for targeted cancer therapies? A systematic review

How are we evaluating the costeffectiveness of companion biomarkers for targeted cancer therapies? A systematic review
21    40    1
Efficacy and safety of HER2 inhibitors in combination with or without pertuzumab for HER2-positive breast cancer: A systematic review and meta-analysis

Efficacy and safety of HER2 inhibitors in combination with or without pertuzumab for HER2-positive breast cancer: A systematic review and meta-analysis
15    53    0
Changes in therapy and survival of metastatic renal cell carcinoma in Estonia

Changes in therapy and survival of metastatic renal cell carcinoma in Estonia
7    70    0
MTH1 deficiency selectively increases noncytotoxic oxidative DNA damage in lung cancer cells: More bad news than good

MTH1 deficiency selectively increases noncytotoxic oxidative DNA damage in lung cancer cells: More bad news than good
15    86    0
Case report: Rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB gene

Case report: Rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB gene
7    58    0
Inhibition of GPR30 by estriol prevents growth stimulation of triple-negative breast cancer cells by 17β-estradiol

Inhibition of GPR30 by estriol prevents growth stimulation of triple-negative breast cancer cells by 17β-estradiol
12    67    0
Mucinous, endometrioid, and serous ovarian cancers with peritoneal dissemination are potent candidates for Pcadherin targeted therapy: A retrospective cohort study

Mucinous, endometrioid, and serous ovarian cancers with peritoneal dissemination are potent candidates for Pcadherin targeted therapy: A retrospective cohort study
9    42    1
Efficacy of systemic oncological treatments in patients with advanced esophageal or gastric cancers at high risk of dying in the middle and short term: An overview of systematic reviews

Efficacy of systemic oncological treatments in patients with advanced esophageal or gastric cancers at high risk of dying in the middle and short term: An overview of systematic reviews
18    246    1
Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma

Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma
7    74    0
Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P43

Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P43
10    47    0
Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P1

Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P1
10    50    0
Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P2

Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P2
10    54    0
Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P3

Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P3
10    40    0
Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P4

Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P4
10    36    0
Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P5

Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P5
10    35    0
Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P6

Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P6
10    42    0
Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P7

Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P7
10    51    0
Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P8

Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P8
10    42    0
Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P9

Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P9
10    51    0
Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P10

Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P10
10    42    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.